The total return over the past 12 months is -32.23% vs. +23.09% for the S&P 500. So far it's up -32.96% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (32.23%) | +0.53% | +23.91% | N/A | N/A | N/A |
| Total Return CAGR | (32.23%) | +0.53% | +23.91% | N/A | N/A | N/A |
| Revenue CAGR | +30.24% | +74.74% | +90.79% | N/A | N/A | N/A |
| Net Income CAGR | +251.23% | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | +244.52% | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +345.96% | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
TransMedics Group, Inc. (TMDX)
| Year | Start price | End price | TMDX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $121.65 | $81.55 | (32.96%) | +11.70% | (44.66%) |
| 2025 | $62.35 | $121.65 | +95.11% | +17.72% | +77.39% |
| 2024 | $78.93 | $62.35 | (21.01%) | +24.89% | (45.90%) |
| 2023 | $61.72 | $78.93 | +27.88% | +26.19% | +1.69% |
| 2022 | $19.16 | $61.72 | +222.13% | (18.17%) | +240.30% |
| 2021 | $19.90 | $19.16 | (3.72%) | +28.74% | (32.46%) |
| 2020 | $19.01 | $19.90 | +4.68% | +18.37% | (13.69%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
